Plain-English translation of NCT05883436 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying the DEXA-C Anterior Cervical Interbody System, a surgical implant designed to help treat neck problems caused by degenerative disc disease—when the discs in your cervical spine (neck) wear down over time. The device is placed during surgery to help stabilize your spine and relieve pain and nerve-related symptoms in your arms. Researchers are collecting information from patients who receive this implant to understand how well it works and what outcomes to expect.
Many people suffer from neck pain and arm symptoms caused by worn-out spinal discs that press on nerves. This trial exists to gather real-world data about how the new implant performs in treating these problems and to make sure it's safe and effective for patients.
If you qualify, you will receive the DEXA-C spinal implant surgery through an open anterior approach (an incision in the front of your neck). After surgery, the study team will follow your progress and collect data about your symptoms, pain levels, and overall outcomes to evaluate how well the implant works for treating your neck problems. You'll likely have follow-up visits and possibly imaging scans to monitor your recovery and fusion progress.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States
Sponsor
Aurora Spine and Pain
Enrollment target
~71 participants
Started
February 2023
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2026.